Welcome

The Medicine and Biotechnology PMP was established in 2023 following the merger of the AIDS and Infectious Diseases PMP with the Brain and Behavior PMP and has since then worked with a combined approach to study and predict epidemics that could prove catastrophic for the entire planet and for all humanity. Follow the topics discussed and the possible preventive strategies.

The Medicine and Biotechnology PMP

The Medicine and Biotechnology PMP, established in 2023 following the merger of the AIDS and Infectious Diseases PMP with the Brain and Behavior PMP, will monitor all diseases that could prove catastrophic for the entire planet and for all humanity. In particular the PMP will focus on infectious diseases caused by zoonotic pathogens, with the potential to cause epidemics, and non-communicable diseases with increasing prevalence due to environmental contamination related to anthropogenic mutagens and/or carcinogens.  

About us

A PMP focused on biomedicine issues was established in the 1980s by Professor Antonino Zichichi and the World Federation of Scientists. A major global emergency is posed by communicable and non-communicable diseases linked to the environment and exogenous agents.

The August Plenary Session presentations of the Medicine and Biotechnology PMP have been focused on the COVID update by Franco Maria Buonaguro and Massimo Ciccozzi 

COVID update

Massimo Ciccozzi focused on the COVID genetic evolution  and the laboratory origin.

Precipitating peptide

Sofie Nyström reported their studies on peptides- related diseases

Brain diseases

Felice Iasevoli and Emanuele Buratti reported on brain diseases associated to precipitating molecules

Infectious Diseases 

Sam Mbulaiteye and Hyshwar Gilada reported on pathogen related Acute infections and Cronique infections progressin to Cancer

Risk of new Technologies

Al reported on the risk associated to innovative therapeutic strategies not-ewll characterized before the applications in humans 

The VEXA Syndrom

Young Neal reported on the newly discovered ASL syndrome associated to somatic mutation-based non cancer diseases.

Medicine and Biotechnolgy PMP sessions were held in previous years during the Planetary Emergency Seminars

2024 M&B Report 

The M&B 2024 report is listed as the second session of the 2024 general report of the entire seminar

2023 M&B Report

The M&B 2023 report is listed as the second session of the 2023 general report of the entire seminar

2022 M&B Report

The M&B 2022 report is listed as the ...

2021 M&B Report

The M&B 2021 report is listed as the ...

The current members of the Medicine and Biotechnology PMP are individualli introduced in this section of the Website 

Knowledge shared, growth achieved

We are proud of our commitment and excellence in every aspect of our service. Discover what we can offer you and how we can contribute to your success in the fields of medicine and biotechnology.

"I am extremely satisfied with the exceptional service I received. Their team went above and beyond to meet our needs and exceeded our expectations."

[[Name]]

"I am extremely satisfied with the exceptional service I received. Their team went above and beyond to meet our needs and exceeded our expectations."

[[Name]]

"I am extremely satisfied with the exceptional service I received. Their team went above and beyond to meet our needs and exceeded our expectations."

[[Name]]

Contact us

Address

[[Address line 1]]
[[Address line 2]]